Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014, Article ID 787529, 8 pages
http://dx.doi.org/10.1155/2014/787529
Research Article

A Disturbance Rejection Framework for the Study of Traditional Chinese Medicine

1Department of Electrical and Computer Engineering, Cleveland State University, Cleveland, OH 44115, USA
2School of Pre-Clinical Medicine, Beijing University of Chinese Medicine, Beijing 100029, China

Received 28 March 2014; Accepted 9 May 2014; Published 4 June 2014

Academic Editor: Si-Yuan Pan

Copyright © 2014 Han Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Xie, “The theory fountainhead of Chinese medical development,” Journal of Henan Medical College for Staff and Workers, vol. 12, pp. 29–30, 2000. View at Google Scholar
  2. P. Li and S. Zao, “The origin of the TCM academic schools and yellow emperor's canon of medicine,” Journal of Changchun University of Traditional Chinese Medicine, vol. 28, pp. 7–8, 2012. View at Google Scholar
  3. N. Wiener, Cybernetics: Or the Control and Communication in the Animal and the Machine, The MIT Press, Cambridge, Mass, USA, 1948.
  4. H. S. Tsien, Engineering Cybernetics, McGraw-Hill, New York, NY, USA, 1954.
  5. J. Han, “From PID to active disturbance rejection control,” IEEE Transactions on Industrial Electronics, vol. 56, no. 3, pp. 900–906, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. Z. Gao, “On the centrality of disturbance rejection in automatic control,” ISA Transactions, vol. 463, pp. 11–16, 2013. View at Google Scholar
  7. Z. Gao, “Engineering cybernetics: 60 years in the making,” Control Theory and Applications, vol. 12, no. 2, pp. 97–109, 2014. View at Google Scholar
  8. N. Wiener, Cybernetics or the Control and Communication in the Animal and the Machine, The MIT Press, Cambridge, Mass, USA, 2nd edition, 1961.
  9. K. J. Åström and P. R. Kumar, “Control: a perspective,” Automatica, vol. 50, pp. 3–43, 2014. View at Google Scholar
  10. J. Han, “Control theory: the doctrine of model or the doctrine of control?” System Science and Mathematics, vol. 9, pp. 328–335, 1989. View at Google Scholar
  11. Z. Gao, “On the foundation of active disturbance rejection control,” Control Theory and Applications, vol. 30, pp. 1498–1510, 2013. View at Google Scholar
  12. Z. Gao, “Active disturbance rejection control: a paradigm shift in feedback control system design,” in Proceeding of the American Control Conference (ACC '11), pp. 2399–2405, Minneapolis, Minn, USA, June 2006. View at Scopus
  13. J. Vincent, D. Morris, N. Usher et al., “On active disturbance rejection based control design for superconducting RF cavities,” Nuclear Instruments and Methods in Physics Research A: Accelerators, Spectrometers, Detectors and Associated Equipment, vol. 643, no. 1, pp. 11–16, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Wu, S. Zhou, and X. Xie, “Design and control of an electromagnetic fast tool servo with high bandwidth,” IET Electric Power Applications, vol. 5, no. 2, pp. 217–223, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Kotina, Q. Zheng, A. J. van den Bogert, and Z. Gao, “Active disturbance rejection control for human postural sway,” in Proceeding of the American Control Conference (ACC '11), pp. 4081–4086, San Francisco, Calif, USA, July 2011. View at Scopus
  16. Y. Wang, H. Zhang, and Z. Gao, “On the disturbance rejection paradigm as applied to the study of chinese medicine,” in Proceeding of the International Conference on Bioinformatics and Biomedical Engineering, pp. 727–732, 2012.
  17. R. E. Kalman, “Canonical structure of linear dynamical systems,” Proceedings of the National Academy of Sciences of the United States of America, vol. 48, no. 4, pp. 596–600, 1962. View at Google Scholar
  18. Z. Li, Yi Zong Bi Du, People's Medical Publishing House, 2006.
  19. T. Takehara, “Antiviral therapy for chronic hepatitis C: current status and perspectives,” Yakugaku Zasshi, vol. 130, no. 2, pp. 143–156, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Wang, M. Li, and S. Meng, Internal Medicine of Traditional Chinese Medicine, Shanghai Science and Technology Press, Shanghai, China, 2005.
  21. S. Ueno, D. Aoki, F. Kubo et al., “Roxithromycin inhibits constitutive activation of nuclear factor κB by diminishing oxidative stress in a rat model of hepatocellular carcinoma,” Clinical Cancer Research, vol. 11, no. 15, pp. 5645–5650, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Qi, X. Chen, C.-Y. Chan et al., “Two-dimensional differential gel electrophoresis/analysis of diethylnitrosamine induced rat hepatocellular carcinoma,” International Journal of Cancer, vol. 122, no. 12, pp. 2682–2688, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. T. A. Zimmers, X. Jin, J. C. Gutierrez et al., “Effect of in vivo loss of GDF-15 on hepatocellular carcinogenesis,” Journal of Cancer Research and Clinical Oncology, vol. 134, no. 7, pp. 753–759, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Maass, F. R. Thieringer, A. Mann et al., “Liver specific overexpression of platelet-derived growth factor-B accelerates liver cancer development in chemically induced liver carcinogenesis,” International Journal of Cancer, vol. 128, no. 6, pp. 1259–1268, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Jiao, X. Liu, W. Mao et al., “Preventive effect of curcumin on DEN-induced hepatic precancerous lesions in mice,” China Pharmacist, vol. 15, pp. 1218–1221, 2012. View at Google Scholar
  26. W. Mao, Y. Song, J. Zhang et al., “Effect of ursolic acid on DEN-induced hepatic precancerous lesions in mice,” Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases, vol. 22, pp. 287–292, 2012. View at Google Scholar
  27. L. Feng, W. Mao, J. Zhang et al., “Pharmacokinetic variations of tetramethylpyrazine phosphate after oral administration in hepatic precancerous mice and its hepatoprotective effects,” Drug Development and Industrial Pharmacy, vol. 40, no. 1, pp. 1–8, 2014. View at Publisher · View at Google Scholar
  28. J. Zhang, L. Feng, W. Mao et al., “Effects of baicalin on liver functions In bepatic precancerous mice induced by diethylnitrosamine,” China Journal of Traditional Chinese Medicine and Pharmacy, vol. 28, pp. 2730–2732, 2013. View at Google Scholar
  29. Y. Song, X. Liu, L. Feng et al., “Pharmacokinetic study of paeonol in liver cancer model rat,” Chinese Journal of Experimental Traditional Medical Formulae, vol. 18, pp. 145–148, 2012. View at Google Scholar